Haferkamp S, Schilling B, Berking C, Drexler K, et al. Breaking primary checkpoint inhibitor resistance with intermittent alkylating chemotherapy in patients with metastatic melanoma - Results of a multicenter phase II study. Br J Dermatol 2025 Sep 4:ljaf350. doi: 10.1093.
PMID: 40905153